# Efficacy of Intravenous Levetiracetam in Neonatal Seizures

> **NCT01720667** · PHASE1,PHASE2 · COMPLETED · sponsor: **Richard H. Haas** · enrollment: 280 (actual)

## Conditions studied

- Neonatal Seizures

## Interventions

- **DRUG:** Intravenous levetiracetam
- **DRUG:** Intravenous phenobarbital

## Key facts

- **NCT ID:** NCT01720667
- **Lead sponsor:** Richard H. Haas
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2017-10-31
- **Final completion:** 2019-07-31
- **Target enrollment:** 280 (ACTUAL)
- **Last updated:** 2019-08-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01720667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01720667, "Efficacy of Intravenous Levetiracetam in Neonatal Seizures". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01720667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*